-
-
If infection preventionists can work their way out of the current wilderness of change, there is some feeling they may be poised for a leadership role in a health care system becoming painfully aware of the power of prevention.
-
Editor's note: Peter J. Pronovost, MD, PhD is a professor in the departments of anesthesiology and critical care, surgery, and health policy and management at the Johns Hopkins University School of Medicine.
-
Increasing the possibility of hospital outbreaks via undiagnosed cases, measles infection has hit the United States at epidemic levels this year. More measles cases were reported in the first seven months of 2008 than during the same period in any year since 1996, according to the Centers for Disease Control and Prevention.
-
What often are called "compassionate use" drugs are investigational new drugs (INDs) in later phase trials where the FDA has allowed the sponsor to apply for an individual treatment IND.
-
Methamphetamine ("meth") addicts are one of the more difficult research populations to recruit both for the erratic lifestyles many have and the illicit drug's tendency to make people paranoid.
-
It's one thing to sense that IRBs are demanding more and are becoming more cautious during protocol reviews. But it's the rare principal investigator who has a long, multi-site study in which it's readily apparent that the IRB reviews have become more rigorous.
-
-
A recent judge's ruling has shaken up the clinical research industry as experts try to determine how the court's interference in an investigational drug study might impact future CT recruitment.
-
One of the key strategies to retaining clinical trial enrollment, particularly when the participants are from vulnerable populations, is exhibiting respect and a nonjudgmental attitude during all encounters, an expert says.
